Key PointsQuestionWhat is the incremental prognostic value of urinary albumin excretion for cardiovascular risk assessment in patients with diabetes with and without the incorporation of cardiac biomarkers? FindingsIn this secondary analysis of a randomized clinical trial population of 15 760 patients with type 2 diabetes and high cardiovascular risk, there was a stepwise increased risk of cardiovascular events according to baseline urinary albumin to creatinine ratio. The association with increased risk was present even at low-level elevations of urinary albumin to creatinine ratio, which are otherwise considered normal, although this relationship was attenuated when adjusted for cardiac biomarkers. MeaningLow levels of albuminuria improve risk stratification for future cardiovascular risk in patients with type 2 diabetes; urinary albumin to creatinine ratio provides minimal incremental prognostic utility beyond cardiac biomarkers.
JAMA Cardiology – American Medical Association
Published: Feb 6, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud